SIX:GALD
Galderma Group AG · SIX · Healthcare · CHF · FY for 2025
Figures on this page computed 2026-11-08 05:43 UTC
Last close
n/aCHF
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
85.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
- Computed from the filing for 2025
7.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
11.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
19.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
0.34Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
Price is the furthest below its sector's middle: 0.11 against 0.37 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.21x
Its own average over 5 years, 4.34B.
- Profit5.56x
Its own average over 5 years, 110.3M.
- Free cash flow3.95x
Its own average over 5 years, 261.1M.
- Debt0.64x
Its own average over 5 years, 4.33B.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 5.56 times.
It reports in USD and trades in CHF. Nothing on this page is converted between the two.
The filed years, as a table
5Each line is 100 at 2021-12-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2021-12-31 | 100.0 | 100.0 |
| 2022-12-31 | 113.7 | 100.0 |
| 2023-12-31 | 125.5 | 100.0 |
| 2024-12-31 | 143.1 | 100.0 |
| 2025-12-31 | 153.4 | 99.7 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- USD
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- USD
Figures behind the shape
Growth
141.0%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
One-year change in net income141.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
Returns on capital
7.8%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital7.8%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity7.5%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets4.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
68.9%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin68.9%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin15.8%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin11.7%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin19.7%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
85.9xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings85.9x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
- Computed from the filing for 2025
Price to book6.8x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio10.6x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.34safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.34
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.19
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage5.5x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score7.62
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
6.7%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
Payout ratio6.7%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio25.1x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CHF
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.